What is INNOVO

Science and innovation thumbnail

An open innovation platform aiming to accelerate innovative drug discovery and development

Our Capability

Partner with us thumbnail

The extensive resource and scientific excellence ensure that we maintain our leading position

Our Goal

Partner with us thumbnail

Looking for innovative discovery as well as novel platforms and technologies in the focused disease areas

Our Collaboration Model

Pipeline thumbnail

Build sustainable relations for long-term collaborations based on trust and apply flexible engagement models


What is INNOVO?

INNOVO is an open innovation platform established by Novo Nordisk Research Centre China. The INNOVO program enables open innovation partnerships with Novo Nordisk to deliver innovative drug discovery in serious chronic metabolic diseases and bring best treatments to patients around the globe.

INNOVO是什么

我们的实力

Our Capability

As an integral part of the Novo Nordisk global R&D organization, we work closely with colleagues across Europe and US to continuously expand the boundaries in innovative drug discovery and development. The extensive resource and scientific excellence we pride ourselves on ensure that we maintain our leading position and strong expertise in:

• In-depth disease and patient understanding

• Solid platforms for drug discovery and clinical development

• Process development and manufacturing capabilities of therapeutic proteins and peptides

• Widely recognized ethical standards


Our Goal

Novo Nordisk is looking for innovative discovery in the focused disease areas including diabetes, obesity, cardiovascular disease (CVD), non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), as well as novel platforms and technologies related to protein engineering and delivery, oligonucleotide and stem cell therapies.

我们的目标


我们的合作模式

Our Collaboration Model

• We build sustainable relations for long-term collaborations based on trust.

• We are flexible in our engagement models.


了解更多